Manufacturers Life Insurance Company, The Cure Vac N.V. Transaction History

Manufacturers Life Insurance Company, The

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$6.5 - $10.77 $130,559 - $216,326	-20,086 Reduced 16.48%	101,793 $695,000
Q2 2023 Aug 11, 2023	BUY	$6.69 - $12.25 $645,444 - $1.18 Million	96,479 Added 379.84%	121,879 $1.27 Million
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $615,536 - $1.21 Million	96,479 Added 379.84%	121,879 $849,000
Q4 2022 Aug 11, 2023	SELL	$5.75 - $8.5 $554,754 - $820,071	-96,479 Reduced 79.16%	25,400 $153,000
Q4 2022 Feb 13, 2023	BUY	$5.75 - $8.5 $146,050 - $215,900	25,400 New	25,400 $153,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.